Literature DB >> 11544275

Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie.

P Aucouturier1, F Geissmann, D Damotte, G P Saborio, H C Meeker, R Kascsak, R Kascsak, R I Carp, T Wisniewski.   

Abstract

Transmissible spongiform encephalopathies display long incubation periods at the beginning of which the titer of infectious agents (prions) increases in peripheral lymphoid organs. This "replication" leads to a progressive invasion of the CNS. Follicular dendritic cells appear to support prion replication in lymphoid follicles. However, the subsequent steps of neuroinvasion remain obscure. CD11c(+) dendritic cells, an unrelated cell type, are candidate vectors for prion propagation. We found a high infectivity titer in splenic dendritic cells from prion-infected mice, suggesting that dendritic cells carry infection. To test this hypothesis, we injected RAG-1(0/0) mice intravenously with live spleen cell subsets from scrapie-infected donors. Injection of infected dendritic cells induced scrapie without accumulation of prions in the spleen. These results suggest that CD11c(+) dendritic cells can propagate prions from the periphery to the CNS in the absence of any additional lymphoid element.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544275      PMCID: PMC209385          DOI: 10.1172/JCI13155

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes.

Authors:  R H Kimberlin; C A Walker
Journal:  J Comp Pathol       Date:  1979-10       Impact factor: 1.311

2.  Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus.

Authors:  H Fraser; A G Dickinson
Journal:  J Comp Pathol       Date:  1978-10       Impact factor: 1.311

3.  Immunodiagnosis of prion disease.

Authors:  R J Kascsak; R Fersko; D Pulgiano; R Rubenstein; R I Carp
Journal:  Immunol Invest       Date:  1997 Jan-Feb       Impact factor: 3.657

4.  Scrapie strains retain their distinctive characteristics following passages of homogenates from different brain regions and spleen.

Authors:  R I Carp; H Meeker; E Sersen
Journal:  J Gen Virol       Date:  1997-01       Impact factor: 3.891

5.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 6.  The physiology of murine germinal center reactions.

Authors:  M H Kosco-Vilbois; J Y Bonnefoy; Y Chvatchko
Journal:  Immunol Rev       Date:  1997-04       Impact factor: 12.988

7.  Pathogenesis of scrapie virus infection in the mouse.

Authors:  C M Eklund; R C Kennedy; W J Hadlow
Journal:  J Infect Dis       Date:  1967-02       Impact factor: 5.226

8.  Reduced susceptibility to scrapie in mice after steroid administration.

Authors:  G W Outram; A G Dickinson; H Fraser
Journal:  Nature       Date:  1974-06-28       Impact factor: 49.962

9.  Preclinical changes in weight of scrapie-infected mice as a function of scrapie agent-mouse strain combination.

Authors:  R I Carp; S M Callahan; E A Sersen; R C Moretz
Journal:  Intervirology       Date:  1984       Impact factor: 1.763

10.  Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens.

Authors:  M C Clarke; R H Kimberlin
Journal:  Vet Microbiol       Date:  1984-07       Impact factor: 3.293

View more
  52 in total

1.  Peripheral prion pursuit.

Authors:  A Aguzzi
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Transmission of prions.

Authors:  C Weissmann; M Enari; P-C Klöhn; D Rossi; E Flechsig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

3.  Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment.

Authors:  Nicole C Kaneider; Arthur Kaser; Stefan Dunzendorfer; Herbert Tilg; Christian J Wiedermann
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.

Authors:  Laura Manuelidis; Zhi Yun Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

5.  Spreading of prions from the immune to the peripheral nervous system: a potential implication of dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2010-03-18       Impact factor: 4.304

Review 6.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 7.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

8.  Interaction between dendritic cells and nerve fibres in lymphoid organs after oral scrapie exposure.

Authors:  Gauthier Dorban; Valérie Defaweux; Caroline Demonceau; Sylvain Flandroy; Pierre-Bernard Van Lerberghe; Nandini Falisse-Poirrier; Joëlle Piret; Ernst Heinen; Nadine Antoine
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

9.  Bacterial colitis increases susceptibility to oral prion disease.

Authors:  Christina J Sigurdson; Mathias Heikenwalder; Giuseppe Manco; Manja Barthel; Petra Schwarz; Bärbel Stecher; Nike J Krautler; Wolf-Dietrich Hardt; Burkhardt Seifert; Andrew J S MacPherson; Irène Corthesy; Adriano Aguzzi
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

10.  Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells.

Authors:  Katarina M Luhr; Elin K Nordström; Peter Löw; Hans-Gustaf Ljunggren; Albert Taraboulos; Krister Kristensson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.